Premarket: European stocks rise, U.S. dollar climbs as Fed rate path pondered

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 32 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 47%
  • Publisher: 92%

Newsletter News

Marketupdate,Tsx,Stocks

U.S. futures flat while oil prices were mired near two-month lows

European stocks rose on Wednesday, boosted by company earnings, while U.S. futures were flat and the dollar climbed as investors assessed the signals on the path for Federal Reserve interest rates.

Global stocks fell sharply in April as strong U.S. economic data caused investors to rein in their bets on rate cuts from the Fed and, by extension, other major central banks this year. “The market is trying to suss out whether data, particularly out of the U.S., is still coming out strong, or is coming out just right,” said Samuel Zief, head of global FX strategy at JPMorgan Private Bank.

In currency markets, the yen dropped 0.5 per cent to 155.42 per dollar even after Bank of Japan governor Kazuo Ueda said the central bank may take monetary policy action if currency falls affect prices significantly.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Premarket: Global stocks sluggish after Fed signals no quick rate cutsU.S. futures up ahead of Apple results; yen backtracks after another suspected intervention
Source: globebusiness - 🏆 31. / 66 Read more »

European shares slip at open in earnings tide, Fed outcomeExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »

European Stocks Slip Amid Earnings Flood, Fed Rate SignalsEuropean stocks posted modest losses on Thursday, pressured by drops across retail and technology and the prospect of higher-for-longer US interest rates. Drugmaker Novo Nordisk A/S slid after sales of its weight-loss drug underwhelmed.
Source: BNNBloomberg - 🏆 83. / 50 Read more »